Published in Glia on April 01, 1999
Astrocyte-induced synaptogenesis is mediated by transforming growth factor β signaling through modulation of D-serine levels in cerebral cortex neurons. J Biol Chem (2012) 1.11
Gap-junctional coupling between neurons and astrocytes in primary central nervous system cultures. Proc Natl Acad Sci U S A (1999) 1.04
Membrane elastic properties and cell function. PLoS One (2013) 1.01
Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation. J Biol Chem (2008) 0.99
Thyroid hormone actions on neural cells. Cell Mol Neurobiol (2002) 0.95
Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. NeuroRx (2005) 0.87
Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases. Inflamm Bowel Dis (2016) 0.84
Connective tissue growth factor (CTGF/CCN2) is negatively regulated during neuron-glioblastoma interaction. PLoS One (2013) 0.83
A comparison of neurotoxicity in cerebellum produced by dermal application of chlorpyrifos in young and adult mice. J Neural Transm (Vienna) (2011) 0.76
Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol. Mol Cancer (2015) 0.75
Derivation of Functional Human Astrocytes from Cerebral Organoids. Sci Rep (2017) 0.75
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell (1994) 3.01
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol (1997) 1.94
Polyoma virus T antigen. I. Synthesis of modified heat-labile T angiten in cells transformed with the ts-a mutant. J Virol (1975) 1.82
Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol (1996) 1.80
Initial expression of neurofilaments and vimentin in the central and peripheral nervous system of the mouse embryo in vivo. J Neurosci (1984) 1.66
Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J Virol (1990) 1.64
Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest (1997) 1.62
The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development (1996) 1.61
Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord (1999) 1.45
Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc Natl Acad Sci U S A (1998) 1.45
Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol (1997) 1.44
Complementary hydropathy identifies a cellular prion protein receptor. Nat Med (1997) 1.43
Human monoclonal IgM with autoantibody activity against intermediate filaments. Proc Natl Acad Sci U S A (1982) 1.31
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med (2000) 1.31
Antibodies as probes of cellular differentiation and cytoskeletal organization in the mouse blastocyst. Exp Cell Res (1980) 1.27
A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev Biol (1998) 1.26
Early segregation of a neuronal precursor cell line in the neural crest as revealed by culture in a chemically defined medium. Cell (1983) 1.26
Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene (1988) 1.24
Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells. EMBO J (1983) 1.22
Vimentin gene: expression in human lymphocytes and in Burkitt's lymphoma cells. EMBO J (1986) 1.21
Genes occupy a fixed and symmetrical position on sister chromatids. Cell (1991) 1.20
Human desmin-coding gene: complete nucleotide sequence, characterization and regulation of expression during myogenesis and development. Gene (1989) 1.13
The importance of intermediate filaments in the adaptation of tissues to mechanical stress: evidence from gene knockout studies. Biol Cell (1997) 1.13
Study of regulation of mitochondrial respiration in vivo. An analysis of influence of ADP diffusion and possible role of cytoskeleton. Biochim Biophys Acta (1997) 1.12
In vitro differentiation of mouse teratocarcinoma cells monitored by intermediate filament expression. Differentiation (1982) 1.10
Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. Braz J Med Biol Res (1999) 1.10
Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development (1993) 1.06
High level desmin expression depends on a muscle-specific enhancer. J Biol Chem (1991) 1.05
Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc Natl Acad Sci U S A (1994) 1.05
Gap-junctional coupling between neurons and astrocytes in primary central nervous system cultures. Proc Natl Acad Sci U S A (1999) 1.04
Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. J Biol Chem (1993) 1.04
Assignment of human desmin gene to band 2q35 by nonradioactive in situ hybridization. Hum Genet (1989) 1.03
Regulation of the trehalose-6-phosphate synthase complex in Saccharomyces. I. Interconversion of forms by phosphorylation. Curr Genet (1987) 1.00
Purification of polyoma T antigen from transformed cells. Biochem Biophys Res Commun (1975) 1.00
Reorganization of the cytoskeleton by interferon in MSV-transformed cells. J Interferon Res (1981) 0.99
Different factors interact with myoblast-specific and myotube-specific enhancer regions of the human desmin gene. J Biol Chem (1993) 0.99
Immunochemical procedure for partial purification of newly synthesized proteins in polyoma virus-infected mouse cells. J Virol (1974) 0.98
Cell cytoskeleton and tether extraction. Biophys J (2011) 0.97
Enzymatic hydrolysis of N-acyl-aminoacyl transfer RNAs. Cold Spring Harb Symp Quant Biol (1969) 0.97
Evidence for a polarity in the distribution of proteins from the cytoskeleton in Torpedo marmorata electrocytes. J Cell Biol (1986) 0.96
An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev Biol (2000) 0.96
Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem (2001) 0.96
The mouse synemin gene encodes three intermediate filament proteins generated by alternative exon usage and different open reading frames. Exp Cell Res (2004) 0.94
Hearts from mice lacking desmin have a myopathy with impaired active force generation and unaltered wall compliance. Cardiovasc Res (2002) 0.94
What can be learned from intermediate filament gene regulation in the mouse embryo. Int J Dev Biol (1995) 0.94
Tropomyosin synthesis accompanies formation of actin filaments in embryonal carcinoma cells induced to differentiate by hexamethylene bisacetamide. Proc Natl Acad Sci U S A (1979) 0.94
Effects of desmin gene knockout on mice heart mitochondria. J Bioenerg Biomembr (2001) 0.93
Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther (1996) 0.93
Nestin is expressed during development and in myotendinous and neuromuscular junctions in wild type and desmin knock-out mice. Exp Cell Res (1999) 0.93
Rearrangement of intermediate filament network of BHK-21 cells infected with vaccinia virus. Arch Virol (1994) 0.93
Mammalian cell lines can be efficiently established in vitro upon expression of the SV40 large T antigen driven by a promoter sequence derived from the human vimentin gene. Biol Cell (1991) 0.93
Human desmin gene: cDNA sequence, regional localization and exclusion of the locus in a familial desmin-related myopathy. Hum Genet (1996) 0.92
PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene (1996) 0.92
Mechanical alterations in smooth muscle from mice lacking desmin. J Muscle Res Cell Motil (1998) 0.92
Lower active force generation and improved fatigue resistance in skeletal muscle from desmin deficient mice. J Muscle Res Cell Motil (2003) 0.91
Differences in the distribution of synemin, paranemin, and plectin in skeletal muscles of wild-type and desmin knock-out mice. Histochem Cell Biol (2000) 0.91
Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax protein. Mol Cell Biol (1993) 0.91
Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J Biol Chem (1992) 0.90
Desmin filaments influence myofilament spacing and lateral compliance of slow skeletal muscle fibers. Biophys J (2004) 0.90
Lack of desmin results in abortive muscle regeneration and modifications in synaptic structure. Cell Motil Cytoskeleton (2001) 0.90
[Familial myopathy with desmin storage seen as a granulo-filamentar, electron-dense material with mutation of the alphaB-cristallin gene]. Rev Neurol (Paris) (2000) 0.90
Different expression of synemin isoforms in glia and neurons during nervous system development. Glia (2006) 0.89
Cross-talk between neurons and glia: highlights on soluble factors. Braz J Med Biol Res (2001) 0.89
[Peptidyl-tRNA hydrolase: demonstration in various organisms. Enzymatic activity in the presence of ribosomes]. Biochimie (1971) 0.89
Absence of desmin slightly prolongs myoblast proliferation and delays fusion in vivo in regenerating grafts of skeletal muscle. Cell Tissue Res (2001) 0.89
Myotube driven myogenic recruitment of cells during in vitro myogenesis. Dev Dyn (1995) 0.88
Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene. Exp Cell Res (1994) 0.88
Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shuttles. Gene Ther (1996) 0.88
Mechanical properties and structure of carotid arteries in mice lacking desmin. Cardiovasc Res (2001) 0.88
Control by the extracellular environment of differentiation pathways in 1003 embryonal carcinoma cells: study at the level of specific intermediate filaments. EMBO J (1982) 0.87
Cell adhesion markers are expressed by a stable human endothelial cell line transformed by the SV40 large T antigen under vimentin promoter control. J Cell Physiol (1993) 0.87
Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ Res (2001) 0.86
Unusual organization of desmin intermediate filaments in muscular dysgenesis and TTX-treated myotubes. Dev Biol (1988) 0.86
Desmin-lacZ transgene expression and regeneration within skeletal muscle transplants. J Muscle Res Cell Motil (1997) 0.86
Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy. FASEB J (2001) 0.86
A 28-bp negative element with multiple factor-binding activity controls expression of the vimentin-encoding gene. Gene (1996) 0.85
Regionally specific properties of midbrain glia: I. Interactions with midbrain neurons. J Neurosci Res (1995) 0.85
Cytoskeleton organization in differentiating mouse teratocarcinoma cells. Biochimie (1981) 0.85
Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. Exp Cell Res (1995) 0.85
Chromosomal localization of the mouse gene coding for vimentin. Genet Res (1989) 0.85
Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology (1999) 0.85
New insights into the role of thyroid hormone in the CNS: the microglial track. Mol Psychiatry (2002) 0.84
Gap junction-mediated coupling in the postnatal anterior subventricular zone. Dev Neurosci (2000) 0.84
Immunochemical identification of desmin in Torpedo postsynaptic membranes and at the rat neuromuscular junction. Synapse (1989) 0.84
Cytoskeletal proteins used as marker of differentiation in mouse terato;carcinoma cells. J Mol Biol (1980) 0.83
Intermediate filament proteins in mouse brain cells cultured in the presence or absence of fetal calf serum. Exp Cell Res (1982) 0.83
Conditional immortalization of normal and dysgenic mouse muscle cells by the SV40 large T antigen under the vimentin promoter control. Dev Biol (1991) 0.83
EcoRV RFLP of the desmin (DES) gene and MspI RFLP of the villin (VIL1) gene on human chromosome 2. Hum Mol Genet (1992) 0.83
A novel site, Mt, in the human desmin enhancer is necessary for maximal expression in skeletal muscle. J Biol Chem (1998) 0.83
Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. II. Interactions with mesencephalic neurons. Brain Res (1986) 0.82
Comparative protein patterns in chromatins from mouse teratocarcinoma cells. Exp Cell Res (1976) 0.82
The cytoskeleton of the electric tissue of Electrophorus electricus, L. An Acad Bras Cienc (2000) 0.82
Role of desmin in active force transmission and maintenance of structure during growth of urinary bladder. Am J Physiol Cell Physiol (2008) 0.82
Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF kappa B: application to the decoy approach. Nucleic Acids Res (1994) 0.81
Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. I. Immunological and pharmacological properties. Brain Res (1986) 0.81
Thyroid hormone induces cerebellar astrocytes and C6 glioma cells to secrete mitogenic growth factors. Am J Physiol Endocrinol Metab (2001) 0.81
Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost (1997) 0.81